Effect of baseline characteristics on mortality in the SURVIVE trial comparing levosimendan and dobutamine in acute heart failure: sub-analysis of the Finnish patients
21 May 2016 (00:00 - 00:00)
Organised by:
About the speaker

Helsinki University Hospital, Helsinki (Finland)
29 More presentations in this session
Doctor N. Farre (Ballinasloe, IE)
Doctor N. Farre (Ballinasloe, IE)
Associate Professor A. Balaceanu (Bucharest, RO)
Access the full session
The Event
HEART FAILURE 2016
21 May - 24 May 2016
